ASTRAZENECA PLC (AZN)
Clinical trial NCT06627647 updates: 1. completion date: 2030-03-25 → 2030-11-18 2. primary completion date: 2029-05-10 → 2030-11-18
Clinical trial NCT06627647 updates: 1. completion date: 2030-03-25 → 2030-11-18 2. primary completion date: 2029-05-10 → 2030-11-18
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical